Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS)

CNY 8.56

(0.59%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 8.8 Billion 8.72 Billion 7.78 Billion 7.27 Billion 7.08 Billion 6.56 Billion
Total Current Assets 3.64 Billion 3.5 Billion 2.7 Billion 2.5 Billion 2.58 Billion 2.93 Billion
Cash And Short Term Investments 799.65 Million 690.07 Million 555.22 Million 648.78 Million 906.25 Million 1 Billion
Cash and Cash Equivalents 798.46 Million 688.81 Million 554.02 Million 647.68 Million 905.1 Million 1 Billion
Short Term Investments 1.19 Million 1.25 Million 1.2 Million 1.09 Million 1.15 Million 1.04 Million
Net Receivables 1.39 Billion 1.32 Billion 910.93 Million 979.95 Million 793.25 Million 796.78 Million
Inventory 1.4 Billion 1.48 Billion 1.2 Billion 869.06 Million 864.15 Million 847.26 Million
Other Current Assets 49.99 Million 13.7 Million 30.51 Million 9.56 Million 21.45 Million 282.38 Million
Total Non-Current Assets 5.15 Billion 5.21 Billion 5.08 Billion 4.76 Billion 4.5 Billion 3.63 Billion
Net PPE 3.88 Billion 4.04 Billion 3.85 Billion 3.74 Billion 3.24 Billion 2.69 Billion
Good Will And Intangible Assets 831.01 Million 749.09 Million 671.83 Million 574.13 Million 539.61 Million 288.66 Million
Good Will - - - - - -
Intangible Assets 831.01 Million 749.09 Million 671.83 Million 574.13 Million 539.61 Million 288.66 Million
Long-Term Investments 329.25 Million 88.58 Million 109.59 Million 88.22 Million 54.68 Million 51.86 Million
Tax Assets 31.02 Million 25.97 Million 21.54 Million 18.82 Million 22.08 Million 20.43 Million
Other Non Current Assets 76.26 Million 308.5 Million 425.46 Million 334.76 Million 643.76 Million 573.85 Million
Other Assets 1.00 - - 1.00 - -
Total Liabilities 4.95 Billion 5.22 Billion 4.39 Billion 3.91 Billion 3.91 Billion 3.49 Billion
Total Current Liabilities 3.51 Billion 4.12 Billion 3.47 Billion 3.12 Billion 3.2 Billion 2.27 Billion
Account Payables 940.06 Million 1.61 Billion 1.17 Billion 1.15 Billion 1.26 Billion 1.04 Billion
Tax Payables 5.89 Million 34.9 Million 19.34 Million 27.6 Million 15.21 Million 27.63 Million
Short Term Debt 2.12 Billion 1.98 Billion 1.99 Billion 1.66 Billion 1.73 Billion 997.94 Million
Deferred Revenue 141.65 Million 216.6 Million 283.11 Million 289.39 Million 131.32 Million 27.63 Million
Other Current Liabilities 309.4 Million 315.03 Million 29.38 Million 16.14 Million 70.15 Million 202.86 Million
Total Non Current Liabilities 1.43 Billion 1.09 Billion 915.91 Million 787.05 Million 716.4 Million 1.22 Billion
Long-Term Debt 1.3 Billion 867.17 Million 693.01 Million 550.95 Million 97.69 Million 742.48 Million
Deferred Revenue Non Current 110.96 Million 100.4 Million 99.04 Million 83.63 Million 52.94 Million 55.87 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 123.85 Million 123.85 Million 123.85 Million 2.79 Million 97.69 Million 9.9 Million
Other Liabilities 0.00 1.00 - 1.00 - -
Total Equity 3.74 Billion 3.5 Billion 3.39 Billion 3.35 Billion 3.17 Billion 3.07 Billion
Stock Holders Equity 3.61 Billion 3.35 Billion 3.25 Billion 3.21 Billion 3.02 Billion 2.92 Billion
Common Stock 896.03 Million 886.88 Million 880.59 Million 880.22 Million 880.22 Million 677.09 Million
Retained Earnings 868.15 Million 684.83 Million 583.24 Million 549.33 Million 363.76 Million 270.91 Million
Accumulated other comprehensive income 586.78 Million 584.33 Million 588.49 Million 578.37 Million 567.53 Million 565.14 Million
Common Stock Equity 3.61 Billion 3.35 Billion 3.25 Billion 3.21 Billion 3.02 Billion 2.92 Billion
Capital Lease Obligation - 1.56 Million 615.57 Thousand 25.8 Million 105.13 Million 194.61 Million
Total Investments 330.44 Million 89.84 Million 110.8 Million 89.32 Million 55.83 Million 52.91 Million
Total Debt 3.43 Billion 2.85 Billion 2.68 Billion 2.21 Billion 1.83 Billion 1.74 Billion
Net Debt 2.63 Billion 2.16 Billion 2.13 Billion 1.56 Billion 926.1 Million 733.56 Million

Balance Sheet Charts